US Stock MarketDetailed Quotes

IVA Inventiva

Watchlist
  • 2.940
  • 0.0000.00%
Trading Mar 25 10:41 ET
279.15MMarket Cap-1.32P/E (TTM)
Intraday
  • 5D
  • Daily
  • Weekly
  • Monthly
  • 1Q
  • 1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Comments

    Jaguar8
    Jaguar8
    Feb 27 05:00
    NEWS
    $Inventiva (IVA.US)$
    Inventiva announces the publication in Biomedicine & Pharmacotherapy of the results from a preclinical study showing improvement of portal hypertension with lanifibranor treatment
    Wednesday, 26th February at 4:00 pm
    • The study demonstrated that lanifibranor improved Portal Hypertension (PH) in mouse models of fibrotic PH and prehepatic non-fibrotic PH
    • Lanifibranor was observed to decrease portal pressure by improving Liver Sinusoidal Endothelial Cell (LSEC) dysfun...
    Jaguar8
    Jaguar8
    Feb 21 05:00
    NEWS
    $Inventiva (IVA.US)$
    Inventiva and Hepalys Pharma, Inc. announce the initiation of the clinical development program of lanifibranor in Japan with the dosing of the first participant in Phase 1 trial
    Thursday, 20th February at 4:00 pm
    • Initiation of the clinical development program of lanifibranor in Japan with the dosing of the first participant in Phase 1 study
    • Positive results could support the initiation of a pivotal Phase 3 trial in patients in Japan with MASH
    • The study represents...
    Jaguar8
    Jaguar8
    Jan 30 05:00
    NEWS
    $Inventiva (IVA.US)$
    Inventiva announces the publication of the results from the investigator-initiated proof-of-concept clinical trial evaluating lanifibranor in patients with T2D and MASLD in the Journal of Hepatology
    Wednesday, 29th January at 4:00 pm
    • As previously reported1, the study met the primary efficacy endpoint for the treatment with lanifibranor 800mg demonstrating a 44% reduction of hepatic fat measured by proton magnetic resonance spectroscopy (1H-MRS) following 24 weeks of t...
    Jaguar8
    Jaguar8
    Jan 23 13:28
    🟤 Watchlist, JANUARY 23,2025, Thursday. NFA
    NOTE!
    1. NFA (Not Financial Advice!) This is NOT a BUY or SELL advice.
    2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
    3. Scale out and secure profits.
    4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
    5. I DO NOT give buy or sell advice
    6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release; FCF (free cash flow)
    7. NEVER be a blind follower.
    8. With regards t...
    17
    9
    Jaguar8
    Jaguar8
    Jan 23 05:00
    NEWS
    $Inventiva (IVA.US)$
    Results of LEGEND evaluating lanifibranor in combination with empagliflozin in MASH selected for oral presentation at the upcoming EASL SLD Summit 2025
    Wednesday, 22nd January at 4:00 pm
    Daix (France), New York City (New York, United States), January 22, 2025 – Inventiva (Euronext Paris and Nasdaq: IVA) ("Inventiva" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of metabolic dysfu...
Read more
Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
KB Home
KBH
+1.59%
Ecopetrol
EC
+0.82%
Petroleo Brasileiro SA Petrobras
PBR
+0.91%
D.R. Horton
DHI
+0.48%
Toll Brothers
TOL
+0.17%

Unlock the Full List